All individual trials at Peter J. Ruane, M.D., Inc.

0 out of 1

0.0%

$29,616,640

Status	Sponsor	Trial ID	Title	Completion date	Days overdue
overdue	Peter J. Ruane, M.D., Inc.	NCT02691728	A Phase 4, Open-Label Study to Investigate the Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic Genotype 1 and 4 HCV Infection With Autoimmune Disease [pACT]	2017-02-28	2590

Download this data